Detalhe da pesquisa
1.
Long-Term Treatment With Long-Acting Injectable Antipsychotic in Schizophrenia Patients With and Without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative Study.
J Clin Psychopharmacol
; 42(4): 357-364, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727084
2.
A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophrenia.
Mol Biol Rep
; 49(3): 2015-2024, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845648
3.
Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia.
Int Clin Psychopharmacol
; 38(2): 102-109, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719338
4.
Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice.
J Psychopharmacol
; 37(10): 992-1002, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395368
5.
Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia.
Front Psychiatry
; 14: 1334335, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476817
6.
Interacting Roles of COMT and GAD1 Genes in Patients with Treatment-Resistant Schizophrenia: a Genetic Association Study of Schizophrenia Patients and Healthy Controls.
J Mol Neurosci
; 71(12): 2575-2582, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125398
7.
Risk factors for early-phase clozapine discontinuation: A nested case-control study.
Asian J Psychiatr
; 62: 102745, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216977